Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab.
Anticancer Res
; 43(2): 841-847, 2023 Feb.
Article
in En
| MEDLINE
| ID: mdl-36697079
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Anticancer Res
Year:
2023
Document type:
Article
Country of publication:
Greece